Further results demonstrated that MAFG-DT increased FZD4/5 expression by targeting miR-24-3p, which activated the Wnt/β-catenin pathway to enhance the ability of cell proliferation, migration, invasion and bone metastasis in PCa cells. The gene discussed is FZD4; the disease is posterior cortical atrophy.